Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study (Q43041911)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 June 2010
edit
Language Label Description Also known as
English
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study
scientific article published on 7 June 2010

    Statements

    Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study (English)
    Wolfgang A Bethge
    Christoph Meisner
    Stephanie von Harsdorf
    Birgit Federmann
    Matthias Stelljes
    Rudolf Trenschel
    Helmut Dittmann

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit